George Kemble insider trades: Sagimet Biosciences (SGMT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where George reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | SGMT | ↓ Sell | 350,987 | $10.23 | $3.6M | Direct | Aug 17, 2026 (3d) |
| Aug 11, 2026 | SGMT | ↓ Sell | 20,206 | $9.95 | $201K | Direct | Aug 12, 2026 (1d) |
| Jul 20, 2026 | SGMT | ↓ Sell | 18,844 | $7.46 | $141K | Direct | Jul 22, 2026 (2d) |
| Nov 20, 2025 | SGMT | ↓ Sell | 37,688 | $7.69 | $290K | Direct | Nov 21, 2025 (1d) |
| Jul 23, 2024 | SGMT | ↓ Sell | 23,625 | $3.17 | $75K | Direct | Jul 25, 2024 (2d) |
| Jul 19, 2024 | SGMT | ↓ Sell | 14,062 | $3.10 | $44K | Direct | Jul 23, 2024 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SGMT insiders
Open-market trades in the last 12 months
About George Kemble's insider trades
George Kemble is an insider at Sagimet Biosciences (SGMT). Since Jul 19, 2024, George has reported no open-market purchases and 6 sales worth $4.3M on SEC Form 4. In the last 12 months: 4 sales ($4.2M).
Their filings also include grants and awards (4 filings), option exercises (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SGMT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.